All In Biotech

Drug Trial Radar · NCT07697456

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

2,000

Planned (sponsor's estimate)

Start

Jul 31, 2026

Primary completion

Oct 2031

Study completion Oct 2031

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Jul 13, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Crohn's disease (CD) and Ulcerative colitis (UC) are 2 types of inflammatory bowel diseases which cause long-lasting, severe inflammation (redness, swelling) in the digestive tract. CD can affect any part of the digestive tract causing many different symptoms including belly pain, diarrhea, tiredness, and weight loss. UC affects the lining of the rectum and colon (large intestine) and can cause bleeding, belly pain, and diarrhea. This platform basket study will evaluate how safe and effective advanced therapies are in adults with moderately to severely active Crohn's Disease (CD) or Ulcerative Colitis (UC). This study currently includes 2 substudies evaluating different treatments in participants with CD or UC. Substudy 1 will evaluate the combination of risankizumab and trosunilimab (ABBV-466) and Substudy 2 will evaluate the combination of risankizumab and ABBV-701 (ABBV-7066). When adult participants with moderately to severely active CD or UC join the study, they will undergo a 2-step randomization within CD and UC substudies, respectively. The first unblinded randomization will assign participants into a substudy, and the second blinded randomization will assign participants to a treatment arm within the assigned substudy. Approximately 100 adult participants will be enrolled per treatment arm across both substudies at approximately 400 sites worldwide. There may be higher treatment burden for participants in this trial compared to their standard of care treatment without participating in this study. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, stool tests, endoscopies, checking for side effects and completing questionnaires and a daily diary.

Conditions

  • Crohn's Disease
  • Ulcerative Colitis

Interventions

  • RisankizumabDrug

    Intravenous/Subcutaneous/Intramuscular Injection/Infusion

  • TrosunilimabDrug

    Intravenous/Subcutaneous/Intramuscular Injection/Infusion

  • ABBV-701Drug

    Intravenous/Subcutaneous/Intramuscular Injection/Infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Crohn's Disease Specific: Percentage of Participants Achieving Endoscopic RemissionTime frame: At Week 28
  2. Ulcerative Colitis Specific: Percentage of Participants who Achieve Endoscopic RemissionTime frame: At Week 28
  3. Number of Participants with Adverse Events (AEs)Time frame: Up to 98 Weeks

Locations

66 sites in 5 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists /ID# 280827

    Dothan, Alabama · Recruiting

  • Elite Clinical Studies /ID# 280477

    Phoenix, Arizona · Recruiting

  • Gi Alliance - Arizona Digestive Health - Sun City /ID# 284084

    Sun City, Arizona · Recruiting

  • Clinnova Research /ID# 280509

    Anaheim, California · Recruiting

  • Southern California Res. Ctr /ID# 280476

    Coronado, California · Recruiting

  • Gastro Care Institute /ID# 281071

    Lancaster, California · Recruiting

  • United Medical Doctors - Los Alamitos /ID# 281125

    Los Alamitos, California · Recruiting

  • Inland Empire Liver Foundation - Rialto /ID# 280775

    Rialto, California · Recruiting

  • Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507

    Colorado Springs, Colorado · Recruiting

  • Synergy Healthcare - Bradenton /ID# 284157

    Bradenton, Florida · Recruiting

  • Clinical Research of Osceola /ID# 280593

    Kissimmee, Florida · Recruiting

  • Florida Center For Gastroenterology - Largo /ID# 281059

    Largo, Florida · Recruiting

  • Research Associates of South Florida /ID# 280929

    Miami, Florida · Recruiting

  • Advanced Research Institute, Inc /ID# 281062

    New Port Richey, Florida · Recruiting

  • Digestive And Liver Center Of Florida - Orlando /ID# 280924

    Orlando, Florida · Recruiting

  • Gcp Clinical Research /ID# 280469

    Tampa, Florida · Recruiting

  • Gastroenterology Associates of Central Georgia /ID# 280464

    Macon, Georgia · Recruiting

  • Gastroenterology Consultants - Roswell /ID# 281235

    Roswell, Georgia · Recruiting

  • Treasure Valley Medical Research /ID# 281778

    Boise, Idaho · Recruiting

  • Midwest Digestive Health & Nutrition /ID# 285250

    Des Plaines, Illinois · Recruiting

  • Gi Alliance - Glenview /ID# 283932

    Glenview, Illinois · Recruiting

  • Illinois Gastroenterology Group /ID# 283933

    Gurnee, Illinois · Recruiting

  • Southwest Gastroenterology - Oak Lawn /ID# 280841

    Oak Lawn, Illinois · Recruiting

  • Gastroenterology Health Partners /ID# 284145

    New Albany, Indiana · Recruiting

  • Gastroenterology Health Partners /ID# 284144

    Louisville, Kentucky · Recruiting

  • Gastro Group and Endocenter: Mandeville, la /ID# 284186

    Mandeville, Louisiana · Recruiting

  • Metropolitan Gastroenterology Associates - Metairie /ID# 283922

    Metairie, Louisiana · Recruiting

  • Willis-Knighton Medical Center /ID# 280572

    Shreveport, Louisiana · Recruiting

  • Lucida Clinical Trials /ID# 282000

    New Bedford, Massachusetts · Recruiting

  • West Michigan Clinical Research Center /ID# 280480

    Wyoming, Michigan · Recruiting

  • Gi Associates - Gia And Endoscopy Center - Flowood /ID# 283967

    Flowood, Mississippi · Recruiting

  • Gastroenterology Associates Of North Mississippi /ID# 285243

    Oxford, Mississippi · Recruiting

  • Specialists In Gastroenterology /ID# 283939

    St Louis, Missouri · Recruiting

  • Vector Clinical Trials /ID# 280843

    Las Vegas, Nevada · Recruiting

  • New York Gastroenterology Associates - Upper East Side /ID# 281767

    New York, New York · Recruiting

  • Digestive Health Partners /ID# 280490

    Asheville, North Carolina · Recruiting

  • Dayton Gastroenterology - Beavercreek /ID# 284065

    Beavercreek, Ohio · Recruiting

  • Gastro Intestinal Research Institute of Northern Ohio /ID# 283860

    Westlake, Ohio · Recruiting

  • University Gastroenterology - Providence - Staniford Street /ID# 280919

    Providence, Rhode Island · Recruiting

  • Gastroenterology Associates - Patewood /ID# 283870

    Greenville, South Carolina · Recruiting

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.